Grifols, S.A.
GRFS stock score: 49/100
$7.54 · -1.31% · Scored Oct 20, 2026
- Technical
- 40
- Fundamental
- 59
- News
- —
The reading
Grifols (GRFS) scores 49 out of 100, which reads weak, higher than 61% of Healthcare stocks and 40% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 40, fundamentals 59.
Among the fundamentals, Fair Value at 100 and Price Target at 100 score highest, while Gross Margins at 3 weighs the most against it.
On the daily chart, trend-following indicators average 51 and contrarian oscillators 36.
Since Jul 25, 2026 the composite has ranged from 45 to 68, and it is down 2 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward GRFS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
59Pulling it up
- Fair Value100
Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Free Cash Flow Yield98
Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.
Holding it back
- Gross Margins3
Gross margins show profitability after cost of goods sold.
- Debt to Equity5
Debt-to-Equity ratio measures financial leverage by comparing total debt to shareholder equity.
- Earnings Growth (5-Year)17
5-year earnings growth evaluates long-term profit trajectory and consistency.
37 weighted scorers; 4 had no data today and are left out rather than counted as zero.
Technical · daily
47Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- EMA 50 Cross Up89
EMA 50 Cross Up detects when price crosses above the 50-period EMA.
- Average True Range (14)80
Average True Range (14-period) measures volatility by calculating the average range between high and low prices.
Holding it back
- Ichimoku Cloud4
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
- SMA 200 Cross Up10
SMA 200 Cross Up tracks when faster moving averages cross above the 200-period SMA.
- S&P 500 52W Comparison13
S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 48 | 1 |
| Daily | 47 | 3 |
| Weekly | 35 | 2 |
| Monthly | 35 | 2 |
| Quarterly | 35 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 20, 2026 | 49 |
| Oct 19, 2026 | 50 |
| Oct 18, 2026 | 51 |
| Oct 17, 2026 | 51 |
| Oct 16, 2026 | 51 |
| Oct 15, 2026 | 50 |
| Oct 14, 2026 | 46 |
| Oct 13, 2026 | 45 |
| Oct 12, 2026 | 47 |
| Oct 11, 2026 | 48 |
| Oct 10, 2026 | 48 |
| Oct 9, 2026 | 48 |
| Oct 8, 2026 | 47 |
| Oct 7, 2026 | 49 |
| Oct 6, 2026 | 49 |
| Oct 5, 2026 | 49 |
| Oct 4, 2026 | 47 |
| Oct 3, 2026 | 47 |
| Oct 2, 2026 | 47 |
| Oct 1, 2026 | 46 |
| Sep 30, 2026 | 46 |
| Sep 29, 2026 | 46 |
| Sep 28, 2026 | 47 |
| Sep 27, 2026 | 47 |
| Sep 26, 2026 | 47 |
| Sep 25, 2026 | 47 |
| Sep 24, 2026 | 46 |
| Sep 23, 2026 | 46 |
| Sep 22, 2026 | 47 |
| Sep 21, 2026 | 46 |
| Sep 20, 2026 | 45 |
| Sep 19, 2026 | 45 |
| Sep 18, 2026 | 45 |
| Sep 17, 2026 | 46 |
| Sep 16, 2026 | 46 |
| Sep 15, 2026 | 45 |
| Sep 14, 2026 | 46 |
| Sep 13, 2026 | 46 |
| Sep 12, 2026 | 46 |
| Sep 11, 2026 | 46 |
| Sep 10, 2026 | 47 |
| Sep 9, 2026 | 50 |
| Sep 8, 2026 | 49 |
| Sep 7, 2026 | 50 |
| Sep 6, 2026 | 50 |
| Sep 5, 2026 | 50 |
| Sep 4, 2026 | 51 |
| Sep 2, 2026 | 51 |
| Sep 1, 2026 | 50 |
| Aug 31, 2026 | 48 |
| Aug 30, 2026 | 48 |
| Aug 29, 2026 | 48 |
| Aug 28, 2026 | 48 |
| Aug 27, 2026 | 49 |
| Aug 26, 2026 | 50 |
| Aug 25, 2026 | 52 |
| Aug 24, 2026 | 51 |
| Aug 23, 2026 | 52 |
| Aug 20, 2026 | 56 |
| Aug 19, 2026 | 50 |
| Aug 18, 2026 | 51 |
| Aug 16, 2026 | 52 |
| Aug 15, 2026 | 51 |
| Aug 14, 2026 | 53 |
| Aug 12, 2026 | 53 |
| Aug 11, 2026 | 53 |
| Aug 10, 2026 | 54 |
| Aug 9, 2026 | 54 |
| Aug 8, 2026 | 54 |
| Aug 7, 2026 | 54 |
| Aug 6, 2026 | 53 |
| Aug 4, 2026 | 54 |
| Jul 31, 2026 | 66 |
| Jul 30, 2026 | 68 |
| Jul 29, 2026 | 68 |
| Jul 28, 2026 | 55 |
| Jul 27, 2026 | 53 |
| Jul 26, 2026 | 51 |
| Jul 25, 2026 | 51 |
Key facts
- Market cap
- $5.1B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Beta
- 1.20
- Risk grade (1–10)
- —
- Next earnings
- Jul 28, 2026
Drug Manufacturers - General peers
| Company | Market cap | Score |
|---|---|---|
| PFE Pfizer | $171.6B | 54 |
| BMY Bristol-Myers Squibb Company | $126.0B | 64 |
| GSK GSK | $101.4B | 61 |
| SNY Sanofi | $99.2B | 48 |
| BIIB Biogen | $35.9B | 58 |
| OGN Organon & | $3.6B | 53 |
Questions
What is GRFS's stock score today?
GRFS scores 49/100 (Weak) as of Oct 20, 2026: technical 40, fundamental 59. Scores are recomputed every night.
Is GRFS a buy?
The score is not a buy or sell recommendation. A 49 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the GRFS score calculated?
98 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.